In 2023, the South East Asia biopharmaceutical market was valued at US$ 18.4 billion. It is projected to reach US$ 37.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.25% from 2024 to 2032. https://www.imarcgroup.com/south-east-asia-biopharmaceutical-market